Effect of topical berberine in murine cutaneous leishmaniasis lesions
Objectives: More effective topical treatments remain an unmet need for the localized forms of cutaneous leishmaniasis (CL). The aim of this study was to evaluate the efficacy and safety of a topical berberine cream in BALB/c mice infected with Leishmania major parasites. Methods: A cream containin...
Những tác giả chính: | , , , , , , , |
---|---|
Định dạng: | info:eu-repo/semantics/article |
Ngôn ngữ: | eng |
Được phát hành: |
Oxford University Press
2022
|
Những chủ đề: | |
Truy cập trực tuyến: | https://hdl.handle.net/10171/64330 |
_version_ | 1793400399590326272 |
---|---|
author | Calvo, A. (Alba) Moreno, E. (Esther) Aldalur, I. (Irati) Sanmartin-Grijalba, C. (Carmen) Larrea, E. (Esther) Gonzalez-Peñas, E. (Elena) Irache, J.M. (Juan Manuel) Espuelas, S. (Socorro) |
author_facet | Calvo, A. (Alba) Moreno, E. (Esther) Aldalur, I. (Irati) Sanmartin-Grijalba, C. (Carmen) Larrea, E. (Esther) Gonzalez-Peñas, E. (Elena) Irache, J.M. (Juan Manuel) Espuelas, S. (Socorro) |
author_sort | Calvo, A. (Alba) |
collection | DSpace |
description | Objectives: More effective topical treatments remain an unmet need for the localized forms of cutaneous leishmaniasis (CL). The aim of this study was to evaluate the efficacy and safety of a topical berberine cream in
BALB/c mice infected with Leishmania major parasites.
Methods: A cream containing 0.5% berberine-β-glycerophosphate salt and 2.5% menthol was prepared. Its
physicochemical and stability properties were determined. The cream was evaluated for its capacity to reduce
lesion size and parasitic load as well as to promote wound healing after twice-a-day administration for 35 days.
Clinical biochemical profile was used for estimating off-target effects. In vitro time-to-kill curves in L. major-infected macrophages and skin and plasma pharmacokinetics were determined, aiming to establish pharmacokinetic/pharmacodynamic relationships.
Results: The cream was stable at 40°C for 3 months and at 4°C for at least 8 months. It was able to halt lesion
progression in all treated mice. At the end of treatment, parasite load in the skin was reduced by 99.9% (4 log)
and genes involved in the wound healing process were up-regulated compared with untreated mice.
The observed effects were higher than expected from in vitro time-to-kill kinetic and plasma berberine concentrations, which ranged between 0.07 and 0.22 μM.
Conclusions: The twice-a-day administration of a topical berberine cream was safe, able to stop parasite progression and improved the appearance of skin CL lesions. The relationship between drug plasma levels and in vivo effect was unclear. |
format | info:eu-repo/semantics/article |
id | oai:dadun.unav.edu:10171-64330 |
institution | Universidad de Navarra |
language | eng |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | dspace |
spelling | oai:dadun.unav.edu:10171-643302022-09-17T01:04:39Z Effect of topical berberine in murine cutaneous leishmaniasis lesions Calvo, A. (Alba) Moreno, E. (Esther) Aldalur, I. (Irati) Sanmartin-Grijalba, C. (Carmen) Larrea, E. (Esther) Gonzalez-Peñas, E. (Elena) Irache, J.M. (Juan Manuel) Espuelas, S. (Socorro) Cutaneous leishmaniasis Berberine Glycerophosphates Menthol Mice Skin Cream Objectives: More effective topical treatments remain an unmet need for the localized forms of cutaneous leishmaniasis (CL). The aim of this study was to evaluate the efficacy and safety of a topical berberine cream in BALB/c mice infected with Leishmania major parasites. Methods: A cream containing 0.5% berberine-β-glycerophosphate salt and 2.5% menthol was prepared. Its physicochemical and stability properties were determined. The cream was evaluated for its capacity to reduce lesion size and parasitic load as well as to promote wound healing after twice-a-day administration for 35 days. Clinical biochemical profile was used for estimating off-target effects. In vitro time-to-kill curves in L. major-infected macrophages and skin and plasma pharmacokinetics were determined, aiming to establish pharmacokinetic/pharmacodynamic relationships. Results: The cream was stable at 40°C for 3 months and at 4°C for at least 8 months. It was able to halt lesion progression in all treated mice. At the end of treatment, parasite load in the skin was reduced by 99.9% (4 log) and genes involved in the wound healing process were up-regulated compared with untreated mice. The observed effects were higher than expected from in vitro time-to-kill kinetic and plasma berberine concentrations, which ranged between 0.07 and 0.22 μM. Conclusions: The twice-a-day administration of a topical berberine cream was safe, able to stop parasite progression and improved the appearance of skin CL lesions. The relationship between drug plasma levels and in vivo effect was unclear. 2022-09-16T07:13:44Z 2022-09-16T07:13:44Z 2022 info:eu-repo/semantics/article https://hdl.handle.net/10171/64330 eng info:eu-repo/semantics/openAccess application/pdf Oxford University Press |
spellingShingle | Cutaneous leishmaniasis Berberine Glycerophosphates Menthol Mice Skin Cream Calvo, A. (Alba) Moreno, E. (Esther) Aldalur, I. (Irati) Sanmartin-Grijalba, C. (Carmen) Larrea, E. (Esther) Gonzalez-Peñas, E. (Elena) Irache, J.M. (Juan Manuel) Espuelas, S. (Socorro) Effect of topical berberine in murine cutaneous leishmaniasis lesions |
title | Effect of topical berberine in murine cutaneous leishmaniasis lesions |
title_full | Effect of topical berberine in murine cutaneous leishmaniasis lesions |
title_fullStr | Effect of topical berberine in murine cutaneous leishmaniasis lesions |
title_full_unstemmed | Effect of topical berberine in murine cutaneous leishmaniasis lesions |
title_short | Effect of topical berberine in murine cutaneous leishmaniasis lesions |
title_sort | effect of topical berberine in murine cutaneous leishmaniasis lesions |
topic | Cutaneous leishmaniasis Berberine Glycerophosphates Menthol Mice Skin Cream |
url | https://hdl.handle.net/10171/64330 |
work_keys_str_mv | AT calvoaalba effectoftopicalberberineinmurinecutaneousleishmaniasislesions AT morenoeesther effectoftopicalberberineinmurinecutaneousleishmaniasislesions AT aldaluriirati effectoftopicalberberineinmurinecutaneousleishmaniasislesions AT sanmartingrijalbaccarmen effectoftopicalberberineinmurinecutaneousleishmaniasislesions AT larreaeesther effectoftopicalberberineinmurinecutaneousleishmaniasislesions AT gonzalezpenaseelena effectoftopicalberberineinmurinecutaneousleishmaniasislesions AT irachejmjuanmanuel effectoftopicalberberineinmurinecutaneousleishmaniasislesions AT espuelasssocorro effectoftopicalberberineinmurinecutaneousleishmaniasislesions |